Group Slooter

Group Slooter

‘Brain at Risk’ is one of the research programs of the Division Anesthesiology, Intensive Care and Emergency Medicine of UMC Utrecht. Our group is interdisciplinary with collaboration of researchers from epidemiology, neurosciences, radiology, neurology, psychiatry, geriatric medicine, rehabilitation medicine, physical therapy, ethics, and pharmacy.

Topics and methods uitklapper, klik om te openen

Delirium – Encephalopathy – Postoperative Cognitive Dysfunction - Outcome after anesthesia-surgery – End-of-life decision making – Post-Intensive Care Syndrome

Methods: Epidemiology – Functional and Structural Imaging – EEG

About uitklapper, klik om te openen

 ‘Brain at Risk’ focusses on delirium and long-term (neuropsychiatric) outcome after anesthesia-surgery and Intensive Care Unit (ICU) admission. Our research group is internationally well-recognized and the leading group in Europe on delirium in ICU patients.

About uitklapper, klik om te openen

Alumni uitklapper, klik om te openen

  • Maarten van Eijk, MD, PhD
  • Willemijn van der Kooi, PhD
  • Tianne Numan, PhD
  • Lotte Kok, DVM, MD, PhD
  • Thomas Ottens, MD, PhD
  • Anne Mette Sauër, MD, PhD
  • Ivo Soliman, MD, PhD
  • Annemiek Wolters, MD, PhD
  • Irene Zaal, MD, PhD

Group members uitklapper, klik om te openen

  • Lotte van Delft, MSc
  • Edwin van Dellen, MD, PhD
  • Prof. Diederik van Dijk, MD, PhD
  • Sandra Dijkstra-Kersten, PhD
  • Celine Gathier, MD
  • Suzanne Hut, PhD
  • Ilse Kant, MSc
  • Monika Kerckhoffs, MD
  • Prof. Dylan de Lange, MD, PhD
  • Lenneke van Lelyveld-Haas, MD
  • Lotte Kok, DVM, MD, PhD
  • Simone Montfort, MSc
  • Nikki de Mul, MD
  • Linda Peelen, PhD
  • Prof. Arjen Slooter, MD, PhD
  • Esther Wesselink, MD

Key publications uitklapper, klik om te openen

  • Van Eijk MMJ, Roes KCB, Honing MLH, Kuiper MA, Karakus A, van der Jagt M, Spronk PE, van Gool WA, van der Mast RC, Kesecioglu J, Slooter AJC. Rivastigmine does not decrease duration of delirium and may increase mortality in critically ill patients: a multicentre, double-blind, randomized, placebo-controlled add-on trial. Lancet 2010;376:1829-37. Impact factor (IF) 47.8.
  • Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D; Dexamethasone for Cardiac Surgery (DECS) Study Group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012 Nov 7;308(17):1761-7. IF= 44.4.
  • Van den Boogaard M, Pickkers P, Slooter AJ, Kuiper MA, Spronk PE, van der Voort PH, van der Hoeven JG, Donders R, van Achterberg T, Schoonhoven L. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 2012;344:e420. IF=20.8.
  • Klein Klouwenberg PMC, Zaal IJ, Spitoni C, Ong DSY, van der Kooi AW, Bonten MJM, Slooter AJC, Cremer OL. The attributable mortality of delirium in critically ill patients. BMJ 2014;349:g6652. IF=20.8.
  • Van den Boogaard M,  Slooter AJC, Brüggemann RJM, Schoonhoven L, Beishuizen A, Vermeijden JW, Pretorius D, de Koning J, Simons KS, Dennesen PJW, Van der Voort PHJ, Houterman S, van der Hoeven JG, Pickkers P; REDUCE Study Investigators. Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial. JAMA 2018;319:680-90. IF= 44.4.

Funding & Grants uitklapper, klik om te openen

  • Netherlands Brain Foundation
  • Netherlands Heart Foundation
  • Netherlands Organization for Scientific Research
  • European Union, European Society of Intensive Care Medicine
  • Technology Foundation STW
  • ZonMW GGG
  • NutsOhra Foundation
  • European Society of Intensive Care / Life Priority Fund

Prizes uitklapper, klik om te openen

  • Clinical Research Award
  • European Society of Intensive Care Medicine

Contact uitklapper, klik om te openen

Are you a fellow scientist and would like more information about working with Brain Center Utrecht? Do you wish to know more about PhD programs and vacancies within the program? Or do you have any other question regarding the Brain Center Utrecht program? Please feel free to contact us. We are happy to help.

Prof. Arjen Slooter, MD, PhD, neurologist-intensivist and professor of Intensive Care Neuropsychiatry.